Evidence map›Paper›PMID 42656729›Full record

ArticleFrontiers in health services2026

Barriers encountered and implementation strategies deployed to facilitate real-world remote symptom monitoring in patients receiving active cancer treatment.

Gabrielle B Rocque, Nicole L Henderson, D'Ambra N Dent, Tanvi V Padalkar, Emma Hendrix, Catherine S Smith, J Nicholas Odom, Tara Kaufmann, Chao-Hui Sylvia Huang, Chelsea McGowan and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in health services, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04809740 (Evaluating the Implementation and Impact of Navigator-delivered ePRO Home Symptom Monitoring and Management), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04809740 naactive not recruitingnot on this map

Evaluating the Implementation and Impact of Navigator-delivered ePRO Home Symptom Monitoring and Management

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2021 to 2027Enrolled3,090ConditionsCancerArmsNavigator-delivered Home ePRO
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gabrielle B Rocque *Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
Nicole L Henderson *Department of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
D'Ambra N DentDepartment of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
Tanvi V PadalkarDepartment of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
Emma HendrixDepartment of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
Catherine S SmithDepartment of Medicine, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.
J Nicholas OdomO'Neal Comprehensive Cancer Center, Birmingham, AL, United States.
Tara KaufmannDell Medical School, University of Texas at Austin, Austin, TX, United States.
Chao-Hui Sylvia HuangDepartment of Medicine, Division of Gerontology, Geriatrics and Palliative Care, University of Alabama at Birmingham, Birmingham, AL, United States.
Chelsea McGowanMitchell Cancer Institute, University of South Alabama; Mobile, AL, United States.
Jennifer Young PierceMitchell Cancer Institute, University of South Alabama; Mobile, AL, United States.
Ethan M BaschDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Justin D SmithDepartment of Population Health Science, University of Utah, Salt Lake, UT, United States.
Angela M StoverDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
North Carolina Translational and Clinical Sciences Institute (NC TraCS)UM1TR004406 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI NICHOLAS J SHAHEEN · 2023 to 2026
$37.5M
UAB Cancer Prevention and Control Training Program (T32)T32CA047888 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Ritu Aneja, Ellen Mary Lavoie Smith · 2018 to 2026
$3.2M
Evaluating the implementation and impact of navigator-delivered ePRO home symptom monitoring and managementR01NR019058 · NINR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROCQUE, GABRIELLE · 2021 to 2025
$3.1M
NCATS NIH HHS UL1 TR002489NCATS NIH HHS UM1 TR004406NCI NIH HHS P30 CA013148NCI NIH HHS T32 CA047888NINR NIH HHS R01 NR019058
6 · The paper itself

Abstract

Background: Remote symptom monitoring (RSM) with electronic patient-reported outcomes (ePROs) impacts patient and health system outcomes, yet data is lacking on real-world barriers to RSM and implementation strategies employed to address barriers. Methods: Guided by the updated Consolidated Framework for Implementation Research 2.0 (CFIR), this two-site implementation evaluation of early RSM implementation and scale-up aimed to evaluate barriers, facilitators, and implementation strategies. Patients and clinical team members were interviewed. Transcripts were coded in NVivo using directed content analysis to categorize barriers and facilitators. The Longitudinal Implementation Strategy Tracking System (LISTS) method was used to track implementation strategies deployed. Incidences where a barrier was reported were linked to strategies employed, creating key barrier-strategy combinations. Kappa for agreement between coders (all >.80). Results: 40 patients and 30 clinical team members (physicians, nurses, nurse practitioners, non-clinical navigators, administrators) completed interviews. Interviewees identified 47 barriers in the CFIR domains. Eight key barrier-strategy combinations were identified by both patients and clinic teams; 13 additional combinations were identified by both groups. Amongst these 21 barrier-strategy combinations, primary barriers addressed related to the innovation (19%), outer setting (10%), the inner setting (19%), individuals (10%), and implementation processes (43%). Unaddressed barriers persisted despite use of multiple implementation strategies. Conclusion: Implementing RSM is complex and requires combinations of implementation strategies to overcome barriers at multiple CFIR levels. Future work is needed to leverage learnings from rigorous implementation studies to facilitate the RSM adoption. Trial registration: NCT04809740, registered 3/18/2021.

Indexed as

CFIREnhancing Oncology Model (EOM)ePROsERICimplementation strategiesmixed methodmulti-levelremote symptom monitoring

Identifiers

PMID42656729
PMCPMC13506834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.